Additional Recombinant COVID-19 Humoral and Cell-Mediated Immunogenicity in Immunosuppressed Populations
Clinical trial NCT06027229 · COMPLETED
Trial details
- NCT number
- NCT06027229
- Sponsor
- University of Wisconsin, Madison
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-20
- Primary completion
- 2024-04-24
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.